Bionano Genomics, Inc. (BNGO)

1.50 -0.02 (-1.32%) USD  |  NASDAQ  |  Jan 16, 16:00
1.50 0.00 (0.00%) After-Hours: 20:00
More

Bionano Genomics Current Deferred Revenue (Per Share)

Current Deferred Revenue (Per Share) Chart

View Current Deferred Revenue (Per Share) for BNGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Per Share) Range, Past 5 Years

View Current Deferred Revenue (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Per Share) Benchmarks

View Current Deferred Revenue (Per Share) Benchmarks
Start Trial
Bruker Corp. Upgrade
Azenta, Inc. Upgrade
Harvard Bioscience, Inc. Upgrade
Precipio, Inc. Upgrade
Kestra Medical Technologies Ltd. --